Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 38.33M | - |
| Gross profit | 569.57K | - |
| Net profit | -2.15M | - |
| EBITDA | -194.31K | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €7.73M |
Number of shares | 662.74M |
52-week high/low | €0.0405 - €0.00982 |
| Dividends | No |
Beta | -1.39 |
P/E ratio | -2.84 |
PEG ratio | 0.01 |
P/B ratio | 0.29 |
P/S ratio | 0.10 |
Company profile
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. Its brands include CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorporated in 2018 and is based in South Yarra, Australia.
| Name | Vitura Health Ltd Ordinary Shares |
| CEO | Justin James |
| Headquarters | South Yarra,
vic Australia |
| Website | |
| IPO | 11/06/2019 |
| Employees | 72 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Australian Securities Exchange Ltd | VIT.AX |
Frankfurt | 1CE0.F |